Objective: In the United States, vascular surgeons frequently perform carotid endarterectomy (CEA). Given the resource burden of unplanned readmission (URA), we sought to identify the predictors and consequences of URA after this common vascular surgery procedure to identify potential points of intervention. Methods: Using a prospective single-institution database, we retrospectively identified consecutive patients undergoing CEA (2001)(2002)(2003)(2004)(2005)(2006)(2007)(2008)(2009)(2010)(2011). Demographic and perioperative factors were prospectively collected. The primary end point was 30-day postdischarge URA after CEA. The secondary end point was 1-year survival. We performed a univariable analysis for URA followed by a multivariable Cox model. A Kaplan-Meier analysis was performed for 1-year survival. Results: During the study period, 840 patients underwent 897 CEAs. The 30-day postdischarge overall readmission rate and URA rate were 8.6% and 6.5%, respectively. Most URA patients (n [ 42; 73.4%) were readmitted for a CEA-related reason (headache, cardiac, hypertension, surgical site infection, bleeding/hematoma, stroke/transient ischemic attack, dysphagia, or hyperperfusion syndrome). Seventeen patients (29.3%) had more than one reason for URA. Median time to URA was 4 days (interquartile range, 1-9 days). Postoperative length of stay, indication for CEA, and discharge destination were not associated with URA. In multivariable analysis, in-hospital occurrence of congestive heart failure (hazard ratio [HR], 15.1; 95% confidence interval [CI], 4.7-48.8; P < .001), stroke (HR, 5.0; 95% CI, 1.8-14.0; P < .001), bleeding/hematoma (HR, 3.1; 95% CI, 1.4-6.9; P [ .003), and prior coronary artery bypass grafting (HR, 2.0; 95% CI, 1.2-3.5; P [ .01) were significantly associated with URA. Patients in the URA group also had decreased survival during 1 year (91% vs 96%; P [ .01, log-rank). Conclusions: The 30-day URA rate after CEA is low (6.5%). Prior coronary artery bypass grafting and in-hospital postoperative occurrence of stroke, bleeding/hematoma, and congestive heart failure identify those at increased risk of URA, and URA signals increased long-term risk of postoperative mortality. (J Vasc Surg 2014;60:77-84.) 
Outcomes evaluation is integral to defining the costeffectiveness of surgical procedures. One outcome that has gained traction as a measure of quality of care and health care resource utilization is hospital readmission within 30 days. Our objective was to precisely estimate the 30-day readmission rate after carotid endarterectomy (CEA), one of the procedures most frequently performed by vascular surgeons in the United States, 1 to understand the factors that contribute to early unplanned readmission (URA) and to identify targets for improvement.
METHODS
Data source. This is an Institutional Review Boarde approved, single-center cohort study of patients undergoing CEA between November 29, 2001, and June 29, 2011. Demographics, comorbidity, intraoperative, and outcome data were captured prospectively in an institutional registry. All combined procedures, including combined coronary artery bypass grafting (CABG)-CEA procedures, were excluded.
Perioperative details. All CEAs were performed by attending vascular surgeons under general anesthesia with routine electroencephalographic (EEG) monitoring. Patients were given acetylsalicylic acid (81 mg or 325 mg) by mouth up to and including the morning of surgery. Endarterectomies were performed in a standard fashion with patch angioplasty closure. Shunting was performed selectively. Protamine was given at the end of the case at the discretion of the surgeon.
Variables and end points. The primary end point was URA, defined as any unanticipated, nonelective hospital readmission within 30 days of date of discharge after CEA. The secondary end point was 1-year survival. A CEA-related reason for readmission was defined as any medical or surgical complication that occurred as a sequela of surgery 2 ; perforated colon cancer is an example of an unplanned and unrelated readmission. Surgical complications were defined as hematoma, surgical site infection, wound dehiscence, or neurologic event (intracerebral hemorrhage, seizure, transient ischemic attack [TIA] , or stroke). A medical complication was defined as any medical condition that occurred as a sequela of CEA. These conditions were broadly grouped into cardiac (eg, congestive heart failure [CHF], myocardial infarction [MI] , arrhythmia, or angina pectoris), headache, hypertension (systolic blood pressure >140 mm Hg), and "other medical problems," including respiratory or pulmonary issues, renal insufficiency, and gastrointestinal problems. Statistical analysis. We performed a univariate analysis for URA with two-tailed Student t-tests for continuous variables (Mann-Whitney U tests for nonparametric continuous variables) and c 2 tests for categorical variables (Fisher exact tests for nonparametric categorical variables), followed by a multivariable Cox model with variables that were statistically significant at the P < .05 level on univariable analysis. The Cochran-Armitage trend test was used to assess for a trend in the annual rate of URA. The Kaplan-Meier method was used to estimate 1-year survival data.
RESULTS
During the study period, 840 patients underwent 897 CEA procedures by 10 vascular surgery attending surgeons. Baseline characteristics are reported in Table I . Median age was 70.1 years (interquartile range [IQR], 64-77 years); 142 patients (15.8%) were octogenarians and eight (0.9%) were nonagenarians. In 102 cases (11.4%), patients were admitted before the day of CEA ("preadmitted"), whereas the rest were admitted on the day of surgery. Median follow-up was 3.4 years (IQR, 1.2-5.2 years).
Most cases were performed under general anesthesia (99.1%) with EEG monitoring (94.3%). One hundred four patients (12.2%) had EEG changes. One hundred sixty-three patients (18.2%) had intraoperative shunts. Drains were placed in 236 (26.4%) cases. Median operating room time was 2.8 hours (IQR, 2.3-3.3 hours).
One hundred twenty-four patients (13.9%) required transfer to the intensive care unit postoperatively, usually in the setting of hypotension (n ¼ 69; 55.6%) or hypertension (n ¼ 38; 30.6%). Median and mean postoperative length of stay (LOS) were 1 day (IQR, 1-2 days) and 2.4 6 4.4 days, respectively. The range was 1 to 66 days. Most patients (n ¼ 837; 93.7%) were discharged to home; of these, 312 (34.9%) were discharged with visiting nurse services. Fifty-eight (6.5%) had a 30-day postdischarge URA. There was no association between LOS and URA (6.0% vs 7.0%; P ¼ .59).
As shown in Table II, 9 .9% of patients (n ¼ 89) suffered at least one in-hospital complication and 2.8% (n ¼ 25) suffered two or more in-hospital complications. Among patients who had a complication, mean and median number of complications was 1.3 6 0.7 and 1 (IQR, 1-2), respectively. The most frequent complication was bleeding or hematoma, which occurred in 4.1% (n ¼ 37) of cases. Three percent (n ¼ 27) of patients required reoperation, usually for a bleeding complication (n ¼ 24; 88.9%). There were 15 postoperative strokes (1.7%), six of which occurred after initial discharge, two of which were disabling, and none of which was fatal. Cause of death was known in three of the five patients who died within 30 days of CEA (ruptured thoracoabdominal aortic aneurysm, Clostridium difficile sepsis, and ischemic colitis). The 30-day stroke or death rate and 1-year death rate were 2.2% and 3.5%, respectively. There were nine patients (1.0%) who did not return for follow-up after discharge within 30 days or by 1 year postoperatively. Seventy-seven patients (8.6%) were readmitted to our institution within 30 days of discharge after index CEA. Of these, 58 (75.3%) readmissions were unplanned, yielding an overall URA rate of 6.5%. There was no trend in annual rate of URA during the period studied (P ¼ .11). All planned readmissions were for elective surgery, including lower extremity revascularization, parotidectomy, mitral valve replacement, hysterectomy, distal pancreatectomy, contralateral CEA, subclavian artery revascularization, and liver resection. Median time to URA was 4 days (IQR, 1-9 days). More than three quarters (77.6%) of URAs occurred within the first 10 days after discharge.
The distribution of reasons for URA is shown in Fig 1 . The most frequent reason for readmission was cardiac, followed by headache, bleeding/hematoma, neurologic event (stroke/TIA/intracerebral hemorrhage), and "other medical reason" (examples include anemia, nausea or vomiting from narcotics, dehydration, mechanical fall, pulmonary embolism, C. difficile colitis, pneumonia, and hypoglycemia). Seventeen patients (29.3%) had more than one reason for URA. In most cases (n ¼ 42; 73.4%), the URA was related to CEA. Seven patients (12%) had a URA unrelated to CEA within 30 days (for the following reasons: ruptured thoracoabdominal aneurysm, mechanical falls, diverticular bleed, hypoglycemia, and ischemic bowel). Three patients were readmitted between 31 and 60 days after surgery and three were readmitted more than 60 days after surgery for a CEA-related reason. These three patients were readmitted for a carotid restenosis, vocal cord medialization for presumed cranial nerve injury during CEA, and latent patch infection.
Seventeen patients (29.3%) in the URA group had at least one additional hospital readmission during 1 year in comparison to 179 patients (21.3%) in the non-URA group.
The results of univariable analysis of factors associated with URA are shown in Table III . Patients requiring URA were more likely to have comorbidities of CHF (13.8% vs 6.0%; P ¼ .02) or prior CABG (34.5% vs 19.1%; P ¼ .005) and to have had postoperative inhospital stroke (6.9% vs 1.0%; P < .001), bleeding/hematoma (12.1% vs 3.6%; P ¼ .002), MI (5.2% vs 1.0%; P ¼ .005), CHF (5.2% vs 0.1%; P < .001), or reoperation (8.6% vs 2.6%; P ¼ .01). Preoperative symptom state, preadmission status, and discharge destination after index hospitalization had no impact on readmission (P ¼ .09, .55, and .89, respectively). There was no significant difference in the index postoperative LOS between patients with and without a URA (median
In the multivariable analysis, in-hospital occurrence of CHF (hazard ratio [HR], 15.1; 95% confidence interval [CI], 4.7-48.8; P < .001), stroke (HR, 5.0; 95% CI, 1.8-14.0; P < .001), bleeding/hematoma (HR, 3.1; 95% CI, 1.4-6.9; P ¼ .003), and prior CABG (HR, 2.0; 95% CI, 1.2-3.5; P ¼ 01) were predictors of URA (Table IV) .
Patients in the URA group had decreased survival during 1 year, as shown in Fig 2 (91% vs 96% ; P ¼ .01, log-rank).
DISCUSSION
In this large, contemporary study, the 30-day sameinstitution URA rate for CEA was 6.5%. Not surprisingly, the most common reasons for URA were related to the procedure. Prior CABG and postoperative in-hospital occurrences of hematoma, stroke, or CHF exacerbation were independent predictors of URA.
Under the Affordable Care Act, Congress enacted the Hospital Readmissions Reduction Program, through which the Centers for Medicare and Medicaid Service (CMS) penalizes hospitals for higher-than-expected rates of risk-adjusted readmissions after acute MI, pneumonia, and heart failure beginning in fiscal year 2013. 3 CMS has proposed to expand the applicable conditions for fiscal year 2015 to include patients admitted for an acute exacerbation of chronic obstructive pulmonary disease and patients admitted for elective total hip arthroplasty and total knee arthroplasty. 3 Patients admitted for vascular procedures may also be added in the near future. 4 We found a low URA rate of 6.5% after CEA. The overall readmission rate (planned or unplanned) was 8.6%, and there was no significant change in the rate of URA during the entire study period. Previously reported 30-day readmission rates after CEA range from 0% to 9.2%. [5] [6] [7] [8] [9] [10] [11] The largest of these studies 6 was a retrospective evaluation of 7019 CEAs at multiple centers between 1990 and 1995. Readmission rates at included centers Our observed overall perioperative complication rate of 9.9% is within the range reported in the literature. In the surgery arm of the North American Symptomatic Carotid Endarterectomy Trial (NASCET), there was an 8.1% rate of perioperative medical complications 12 ; in combination with perioperative nonfatal strokes and death, the overall perioperative complication rate was 14.6%. 13 In the New York Carotid Artery Study of 9308 CEAs performed at 167 centers, the perioperative complication rate (including nonfatal stroke, death, and minor surgical complications) was 13.9%. 14 In the Carotid Revascularization Endarterectomy vs Stenting Trial (CREST), the overall perioperative complication rate in the surgical arm was 13.3%. 15 At the other end of the spectrum, LaMuraglia et al 16 reported a 5.5% overall 30-day complication rate (including stroke/ death, cranial nerve injury, TIA, bleeding, cardiac, pulmonary, infectious, hyperperfusion, renal failure, and miscellaneous events) in a retrospective single-center analysis of 2236 CEAs.
Prior literature demonstrated that the majority of perioperative strokes occur within 6 hours of surgery (eg, NAS-CET trial 13 ) because many of these events are related to technical issues of the endarterectomy site, but there is recent evidence that postdischarge events are also common. Half of the postdischarge neurologic events we observed were related to cerebral hyperperfusion. In 2008, Goodney et al 17 reported that after 3092 CEAs performed at 11 hospitals, 5 of 52 strokes (10%) occurred after discharge but within 30 days of surgery. Kang et al perioperative strokes (33%) occurred after discharge in a total data set of 35,916 CEA patients. Taken together, these data suggest that a significant proportion of events occur after discharge after CEA, which is consistent with our finding that 6 of 15 strokes occurred after discharge.
Any postoperative complication has been implicated as a strong independent predictor of URA after general surgery 20 and carotid procedures 21 alike, and we observed a similar relationship in our study. Of the postoperative inhospital complications we examined (TIA, stroke, seizure, hematoma, dysphagia, respiratory failure, wound infection, arrhythmia, MI, renal failure, and reoperation), only stroke, hematoma, or CHF exacerbation were significantly associated with URA.
The association between URA and CHF is consistent with prior observations that cardiac risk factors (including chronic obstructive pulmonary disease and history of CHF) are associated with LOS after major vascular surgery 22 and that CHF is associated with increased inhospital mortality after carotid revascularization. 23 It is possible that our URA rate may be underestimated or overestimated because of our institution's rate of CHF. However, our hospital's adjusted 30-day readmission rate for heart failure (24.7%) at the time of this report is no different from the national rate of readmission. 24 Prior CABG conferred two times the hazard of URA compared with patients who did not have prior CABG. When the time of prior CABG was dichotomized into recent (within 6 months of CEA) and remote (6 months before CEA or earlier), the correlation with URA was observed only in the remote CABG group, suggesting that the risk for URA stemmed from progression of coronary disease or of coronary risk factors in patients who had undergone CABG.
As regards the negative correlation between URA and survival, further research is needed to identify preventable causes of death and to determine whether mortality is related to carotid disease or a procedure-related complication. However, it is likely that the overall burden of comorbid disease in these patients, rather than the readmission event itself, is associated with mortality.
The use of URA as a quality measure is controversial. Researchers at the Cleveland Clinic used Medicare data to demonstrate that hospitals with higher readmission rates had lower 30-day mortality rates. 25 Similarly, the Greater New York Hospital Association, using data from the CMS's public website, Hospital Compare, demonstrated that mortality is inversely related to readmissions and that states with lowest percentile rankings for morality had the highest adjusted 30-day readmission rates, and vice versa. 26 Unlike administrative databases, our dataset had detailed clinical information that had been prospectively collected for research purposes rather than for billing purposes. We collected data on readmissions 30 days after discharge rather than after the procedure (as in the American College of Surgeons NSQIP database) such that there is no bias toward patients who had a shorter postoperative LOS. Limitations of this study include the single-center, retrospective nature. We were unable to reliably capture readmissions to other hospitals, and hence we included only readmissions to our institution. We traditionally treat post-CEA patients with headache and hypertension aggressively and have a low threshold to readmit them for observation and management, which may have increased our rate of URA in comparison to other centers. Finally, we did not capture sociodemographic and other health care history variables that are potential factors influencing readmission. These include poverty, low English or health literacy, recent admissions, frequent emergency department visits, depression, a home medication list of six or more medications, discharge on a weekend or holiday weekend, lack of understanding of postdischarge plan of care, and delayed or inadequate communication with the next provider of direct care. 27 
CONCLUSIONS
In the setting of this study, the 30-day URA rate after CEA is low (6.5%), but a URA signals increased long-term risk of postoperative mortality. Vascular surgeons across the country should continue to strive toward a zero-event rate with regard to URA. Prior CABG and in-hospital postoperative occurrence of stroke, bleeding/hematoma, and CHF identify those at increased risk of URA. These risk factors may represent modifiable areas to further reduce URA after CEA. Dr Karen J. Ho. This cohort includes the patients of 10 surgeons, and virtually all of them give protamine at the end of the case. Our rate of bleeding complications has decreased over the 10-year study period, possibly because of the initiation of protamine. I think the higher rate of hematoma and bleeding that we report partially reflects the period of time before we were using protamine regularly.
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Dr Ricotta. I just wonder whether maybe the pendulum has gone a little too far in one direction. Why don't you answer that question and then we'll get Dr Moore.
Dr Ho. The mean postoperative length of stay of this cohort was 2.4 days with a range of 1 to 66 days. Using this same patient cohort, we know that increased length of stay is not associated with decreasing unplanned readmissions.
Dr Wesley Moore (Los Angeles, Calif). I have just one question. I noted that you were only capturing readmission to your own hospital. In my institution, I have patients coming from a fair distance away, and I suspect that must be true in your institution as well when you're looking at the experience in a tertiary care medical center. I'm wondering if you're missing readmissions to other hospitals, and would it be possible to go back and find out that information as well?
Dr Ho. That's a very good point. It's one of the weaknesses of a single-center cohort study. Our rate of unplanned readmission is 6.5%. The unplanned readmission rate from a VA study that was published in 2004 was 4%. The readmission rate from the 2011 NSQIP database, which includes readmission data for the first time, is approximately 7%. And a paper that was presented at the Midwestern Vascular Society last year reported an unplanned readmission rate of 8.8% in a Medicare database. So I think even though we are not capturing readmissions that perhaps went to another hospital, our readmission rate is still comparable to contemporary estimates.
We could potentially go back to the charts and see if there are any mentions of readmissions to other centers, but my gut feeling is that patients tend to want to be seen by their surgeon for any problems that occur in the first month postop.
Dr Marat Goldenberg (Cartersville, Ga). Have you looked at the difficulty in stabilizing blood pressure postoperatively within the first 24 hours and correlate that with an appearance of complication or problems whether they result in admissions or not? And if blood pressure was difficult to control, either high or low, should the patient be kept in the hospital for an extra day?
Dr Ho. It's our routine practice to be very aggressive about maintaining systolic blood pressure between 100 and 140 mm Hg. We typically do not discharge patients until their blood pressure is stable within these parameters on an oral medication regimen. A third of our patients went home with a visiting nurse and usually that's for either wound checks or for blood pressure checks. We also have a care coordinator who calls patients post discharge day 1 to check on those issues.
Dr Krishnasamy Soundararajan (Wilmington, Del). I was interested in the group which was admitted for headache. It is generally believed that the chances of reperfusion symptoms are higher in patients with contralateral occlusion or high-grade stenosis. Would you be able to elaborate if you had looked into or if it is worth looking into the status of the contralateral carotid perfusion in those patients with headache?
Dr Ho. The reason why we are very aggressive about readmitting patients with headache and not discharging patients who report a headache is that we are concerned about cerebral hyperperfusion. We have not looked at contralateral carotid occlusion and the incidence of headache.
Dr Matthew Sweet (Seattle, Wash). In light of the discussion about the benefit of carotid endarterectomy in asymptomatic patients, can you infer anything about the patients who had postoperative CHF in terms of helping to better risk stratify patients before the operation? Have these data changed the practice pattern at your hospital, or are there any other lessons we can take away on who maybe shouldn't have an asymptomatic carotid endarterectomy?
Dr Ho. I think we all know that the rate of readmission for patients with CHF is very high. Nationally the average readmission rate is on the order of 20% to 24%. I looked up our hospital's readmission rate for CHF patients and it matches the national average.
I think that once one has determined that a patient is at risk for a postop complication but potentially could also benefit from the surgery, I think one has to accept that there is a risk/benefit ratio to everything one does, understand the factors that contribute to risk, and try to minimize them to the best of one's ability.
